KIM, Kyung Jin,PARK, Hangil,DING, Yi,ZHANG, April,WANG, Lihong,VASQUEZ, Maximiliano
申请号：
EP16847130
公开号：
EP3350217A4
申请日:
2016.09.13
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The present invention is directed toward neutralizing monoclonal antibodies to Vascular Endothelial Growth Factor (VEGF) and angiopoietin 2 (Ang-2), pharmaceutical compositions comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
